Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Farshid A Zandi, M.D
Hospitalist · MUSKOGEE, OK · NPI 1578510657
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 642 | 202 |
| Furosemide | Furosemide | 561 | 96 |
| Levothyroxine Sodium | Levothyroxine Sodium | 478 | 102 |
| Eliquis | Apixaban | 432 | 97 |
| Gabapentin | Gabapentin | 417 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 288 | 98 |
| Trazodone Hcl | Trazodone Hcl | 261 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 237 | 70 |
| Potassium Chloride | Potassium Chloride | 225 | 75 |
| Lisinopril | Lisinopril | 220 | 68 |
| Jardiance | Empagliflozin | 215 | 34 |
| Sertraline Hcl | Sertraline Hcl | 198 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 197 | 41 |
| Buspirone Hcl | Buspirone Hcl | 157 | 36 |
| Carvedilol | Carvedilol | 156 | 56 |
| Losartan Potassium | Losartan Potassium | 144 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 144 | 57 |
| Metformin Hcl | Metformin Hcl | 143 | 46 |
| Levetiracetam | Levetiracetam | 127 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 126 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 120 | 60 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 112 | 33 |
| Famotidine | Famotidine | 105 | 17 |
| Mirtazapine | Mirtazapine | 103 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 98 | 19 |
| Donepezil Hcl | Donepezil Hcl | 90 | 36 |
| Baclofen | Baclofen | 88 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 79 | 19 |
| Xarelto | Rivaroxaban | 75 | 26 |
| Omeprazole | Omeprazole | 74 | 15 |
| Pantoprazole Sodium | Pantoprazole Sodium | 74 | 28 |
| Hydralazine Hcl | Hydralazine Hcl | 70 | 26 |
| Latanoprost | Latanoprost | 69 | 14 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 69 | suppressed |
| Spironolactone | Spironolactone | 69 | 25 |
| Memantine Hcl | Memantine Hcl | 65 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 62 | 29 |
| Divalproex Sodium | Divalproex Sodium | 60 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 60 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 58 | 19 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 57 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 56 | 26 |
| Sevelamer Carbonate | Sevelamer Carbonate | 55 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 17 |
| Januvia | Sitagliptin Phosphate | 54 | suppressed |
| Torsemide | Torsemide | 54 | 30 |
| Gemtesa | Vibegron | 52 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 52 | 14 |
| Montelukast Sodium | Montelukast Sodium | 51 | 23 |
| Morphine Sulfate Er | Morphine Sulfate | 51 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 50 | 13 |
| Entresto | Sacubitril/Valsartan | 48 | suppressed |
| Allopurinol | Allopurinol | 46 | 21 |
| Prednisone | Prednisone | 42 | 22 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 39 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 30 |
| Simvastatin | Simvastatin | 39 | 14 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 38 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 38 | 13 |
| Topiramate | Topiramate | 38 | suppressed |
| Ezetimibe | Ezetimibe | 36 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | 20 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 33 | 25 |
| Midodrine Hcl | Midodrine Hcl | 32 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | 15 |
| Albuterol Sulfate | Albuterol Sulfate | 31 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 31 | 21 |
| Cephalexin | Cephalexin | 31 | 16 |
| Lubiprostone | Lubiprostone | 31 | suppressed |
| Acetic Acid | Acetic Acid | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 29 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | 12 |
| Lamotrigine | Lamotrigine | 28 | 12 |
| Ozempic | Semaglutide | 28 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | 11 |
| Myrbetriq | Mirabegron | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | 14 |
| Meloxicam | Meloxicam | 26 | 12 |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Finasteride | Finasteride | 25 | 13 |
| Morphine Sulfate | Morphine Sulfate | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 23 | 23 |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Folic Acid | Folic Acid | 22 | 11 |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 22 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 22 | 17 |
| Sucralfate | Sucralfate | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | 16 |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Glipizide | Glipizide | 21 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | 16 |
| Risperidone | Risperidone | 21 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 18 |
| Levemir Flexpen | Insulin Detemir | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 18 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Atenolol | Atenolol | 15 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Rexulti | Brexpiprazole | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 11 |
| Glipizide Er | Glipizide | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | 12 |
| Levofloxacin | Levofloxacin | 13 | 11 |
| Lorazepam | Lorazepam | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Alprazolam | Alprazolam | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error